118 related articles for article (PubMed ID: 19665226)
1. Epigenetic modifications in AML and MDS.
Mahmud M; Stebbing J
Leuk Res; 2010 Feb; 34(2):139-40. PubMed ID: 19665226
[No Abstract] [Full Text] [Related]
2. Epigenetic changes in therapy-related MDS/AML.
Voso MT; D'Alò F; Greco M; Fabiani E; Criscuolo M; Migliara G; Pagano L; Fianchi L; Guidi F; Hohaus S; Leone G
Chem Biol Interact; 2010 Mar; 184(1-2):46-9. PubMed ID: 19874806
[TBL] [Abstract][Full Text] [Related]
3. Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions.
Benetatos L; Dasoula A; Hatzimichael E; Syed N; Voukelatou M; Dranitsaris G; Bourantas KL; Crook T
Ann Hematol; 2011 Sep; 90(9):1037-45. PubMed ID: 21340720
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiology of leukemia and MDS among atomic bomb survivors in Hiroshima and Nagasaki suggests how abnormal epigenetic regulation contributes to leukemogenesis].
Inaba T
Rinsho Ketsueki; 2009 Oct; 50(10):1548-52. PubMed ID: 19915365
[No Abstract] [Full Text] [Related]
5. [Methylation status of LINE-1 sequences in patients with MDS or secondary AML].
Römermann D; Hasemeier B; Metzig K; Schlegelberger B; Länger F; Kreipe H; Lehmann U
Verh Dtsch Ges Pathol; 2007; 91():338-42. PubMed ID: 18314632
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndromes (MDSs) and acute myelogenous leukemia (AML) comprise a closely linked continuum of malignant hematologic diseases. Introduction.
Baylin SB; Mufti GJ
Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S1-3. PubMed ID: 16341235
[No Abstract] [Full Text] [Related]
7. Epigenetic signatures as prognostic tools in acute myeloid leukemia and myelodysplastic syndromes.
Christopeit M; Bartholdy B
Epigenomics; 2014; 6(4):371-4. PubMed ID: 25333846
[No Abstract] [Full Text] [Related]
8. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
Bernasconi P
Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
[TBL] [Abstract][Full Text] [Related]
9. Semi-quantitative study of calcitonin gene methylation in myelodysplastic syndrome.
Wu S; Xie G; Bai R; Wang Y; Zhu P
Chin Med J (Engl); 1998 Aug; 111(8):690-3. PubMed ID: 11245020
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of the p15(INK4B) gene in acute leukemia and myelodysplastic syndromes.
Chen H; Wu S
Chin Med J (Engl); 2002 Jul; 115(7):987-90. PubMed ID: 12150726
[TBL] [Abstract][Full Text] [Related]
11. [Epigenetic dysregulation in myelodysplastic syndrome].
Sashida G; Iwama A
Rinsho Ketsueki; 2015 Feb; 56(2):111-8. PubMed ID: 25765789
[TBL] [Abstract][Full Text] [Related]
12. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
13. NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype.
Zhang Y; Zhang M; Yang L; Xiao Z
Leuk Res; 2007 Jan; 31(1):109-11. PubMed ID: 16678898
[TBL] [Abstract][Full Text] [Related]
14. Downregulation but lack of promoter hypermethylation or somatic mutations of the potential tumor suppressor CXXC5 in MDS and AML with deletion 5q.
Treppendahl MB; Möllgård L; Hellström-Lindberg E; Cloos P; Grønbaek K
Eur J Haematol; 2013 Mar; 90(3):259-60. PubMed ID: 23190153
[No Abstract] [Full Text] [Related]
15. Genetic and epigenetic alterations in myelodysplastic syndrome.
Mihara K; Takihara Y; Kimura A
Cytogenet Genome Res; 2007; 118(2-4):297-303. PubMed ID: 18000383
[TBL] [Abstract][Full Text] [Related]
16. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
Swolin B; Rödjer S; Westin J
Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
[TBL] [Abstract][Full Text] [Related]
17. [Distinct genetic pathway in the molecular pathogenesis of MDS/AML with AML1/RUNX1 point mutations].
Harada H
Rinsho Ketsueki; 2007 Jul; 48(7):541-6. PubMed ID: 17695302
[No Abstract] [Full Text] [Related]
18. [Study of nucleophosmin (NPM) gene mutation in patients with acute myeloid leukemia and myelodysplastic syndromes].
Zhang Y; Zhang MR; Yang L; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):470-3. PubMed ID: 17147251
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics in AML.
Melnick AM
Best Pract Res Clin Haematol; 2010 Dec; 23(4):463-8. PubMed ID: 21130408
[TBL] [Abstract][Full Text] [Related]
20. The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia.
Karlic H; Herrmann H; Varga F; Thaler R; Reitermaier R; Spitzer S; Ghanim V; Blatt K; Sperr WR; Valent P; Pfeilstöcker M
Crit Rev Oncol Hematol; 2014 Apr; 90(1):1-16. PubMed ID: 24183913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]